Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clear Cell Renal Cell Carcinoma (ccRCC)
100%
Co-expression Network
100%
Opioid Signaling
100%
Analgesic Drugs
60%
Opioid Effects
60%
Cancer Outcomes
40%
Molecular Mechanism
20%
Disease States
20%
Drug-induced
20%
Drug Effects
20%
Naloxone
20%
Associated Genes
20%
Major Components
20%
Opioids
20%
Enkephalin
20%
Personalization
20%
Cancer Cells
20%
RNA Sequencing (RNA-seq)
20%
Cancer Types
20%
Master Regulator
20%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
20%
Macrophages
20%
Angiogenesis
20%
Pro-survival
20%
Overall Survival
20%
Patients with Cancer
20%
Postoperative Opioids
20%
Transcriptional Profile
20%
Patient Cohort
20%
Opioid Pathway
20%
Fatty Acid Metabolism
20%
Opioid Antagonist
20%
Mechanistic Details
20%
Cancer Genome Atlas
20%
Variety of Evidence
20%
Cancer-specific Survival
20%
Recurrence-free
20%
Long-term Oncological Outcomes
20%
Gene Co-expression Network
20%
Survival Endpoint
20%
Opioid Exposure
20%
Haemopoesis
20%
Medicine and Dentistry
Clear Cell Renal Cell Carcinoma
100%
Malignant Neoplasm
40%
In Vitro
20%
Naloxone
20%
Recurrent Disease
20%
Cancer Cell
20%
Cancer Types
20%
Macrophage
20%
Angiogenesis
20%
Overall Survival
20%
The Cancer Genome Atlas
20%
Fatty Acid Metabolism
20%
Opiate Agonist
20%
RNA Sequence
20%
Drug Effect
20%
Cancer Specific Survival
20%
Leu-Enkephalin
20%
Diseases
20%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Renal Cell Carcinoma
100%
Analgesic Agent
50%
Naloxone
16%
Opiate Agonist
16%
Leucine Enkephalin
16%
Recurrent Disease
16%
Overall Survival
16%
Fatty Acid
16%
Cancer Specific Survival
16%
Diseases
16%